Microbiome Technology Firm Enterome Raises $13.9M | GenomeWeb

NEW YORK (GenomeWeb) – Startup microbiome-based technology firm Enterome said today that it raised €10 million ($13.9 million) in the first tranche of a Series B financing round.

The Paris-based company said that the funding will be used to conduct R&D and business activities. Its technology platform, called the Metagenotyping system, is for developing new tools, such as biomarkers and companion diagnostics, for managing diseases. Eventually, the platform will be used for developing therapeutics for inflammatory bowel and metabolic disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.